News & Events about Lannett Company Inc.
LANNETT RECEIVES FDA APPROVAL TO MANUFACTURE NUMBRINO AT SEYMOUR PLANT LANNETT RECEIVES FDA APPROVAL TO MANUFACTURE NUMBRINO AT SEYMOUR PLANT PR Newswire PHILADELPHIA, Oct. 21, 2022 --Approval Allows Site to Rapidly Expand Liquid Drug Manufacturing-- PHILADELPHIA, Oct. 21, 2022 /PRNewswire...
LANNETT TO REPORT FISCAL 2022 FOURTH-QUARTER, FULL-YEAR FINANCIAL RESULTS, HOST CONFERENCE CALL ON WEDNESDAY, AUGUST 24 LANNETT TO REPORT FISCAL 2022 FOURTH-QUARTER, FULL-YEAR FINANCIAL RESULTS, HOST CONFERENCE CALL ON WEDNESDAY, AUGUST 24 PR Newswire TREVOSE, Pa., Aug. 19, 2022 TREVOSE, Pa., Aug...
Dimensional Fund Advisors LP lessened its position in Lannett Company, Inc. (NYSE:LCI Get Rating) by 11.6% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 865,122 shares of the companys stock after selling 113,453 shares during the period. Dimensional Fund ...
LANNETT Announces sale of liquid drug manufacturing plant and other assets for $10.5 million LANNETT Announces sale of liquid drug manufacturing plant and other assets for $10.5 million --Transaction a Key Element of Company's Plan to Streamline Operations and Reduce Costs; Proceeds Further...